Trial Profile
A study investigating the effect of nilotinib on gene expression profiling of Cd34+/Lin- cells in chronic myeloid leukemia patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Dec 2015
Price :
$35
*
At a glance
- Drugs Nilotinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Pharmacodynamics
- 10 Dec 2015 New trial record